Analyst Ratings for BridgeBio Pharma (BBIO)
BBIO Rating Summary
BBIO Price Target Summary
- Highest: $60.00 (Cantor Fitzgerald)
- Lowest: $33.00 (Jefferies)
- Average: $47.45
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$47.45 (+86.4%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 89%
Avg. $ Target:
$47.45 (+86.4%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/20/2024 | Raymond James | Danielle Brill | New Coverage | Outperform (N/A) |
45.00 (N/A) |
28.43 (25.46) |
-10.45% | Details |
| 1/31/2024 | BMO Capital | Kostas Biliouris | New Coverage | Market Perform (N/A) |
37.00 (N/A) |
37.84 (25.46) |
-32.72% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
